2025-10-11 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided.

**Report: Albemarle Corp (ALB) Analysis**

Albemarle Corporation is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.

**1. Performance vs. S&P 500 (VOO)**

*   **ALB Cumulative Return:** -13.29%
*   **VOO Cumulative Return:** 99.08%
*   **Absolute Divergence:** -111.1
*   **Relative Divergence:** 3.0

**Analysis:** ALB has significantly underperformed the S&P 500. The large negative divergence indicates substantial relative weakness. A relative divergence of 3.0 suggests ALB's performance is near the low end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       |   CAGR |   MDD |   Alpha |   Beta |   Cap(B) |
|:-----------|-------:|------:|--------:|-------:|---------:|
| 2015-2017  |   85   |  68   |    56   |    0.1 |     15.1 |
| 2016-2018  |    9   |  68   |    -6   |    0.0 |      9.1 |
| 2017-2019  |  -44   |  73.9 |   -66   |    0.1 |      8.6 |
| 2018-2020  |   44   |  79.4 |    20   |    0.2 |     17.4 |
| 2019-2021  |  149   |  79.4 |   103   |   -0.1 |     27.5 |
| 2020-2022  |  148   |  79.9 |   149   |    0.5 |     25.6 |
| 2021-2023  |  -26   |  81.9 |   -27   |    0.5 |     17   |
| 2022-2024  | -152   |  81.9 |  -172   |    0.3 |     10.1 |
| 2023-2025  | -235   |  81.9 |  -298   |   -0.4 |     10.6 |

**Analysis:**

*   **CAGR and MDD:**  The CAGR (Compound Annual Growth Rate) shows periods of very high growth (e.g., 2019-2021, 2020-2022) and significant declines more recently (2022-2025).  MDD (Maximum Drawdown) has been consistently high, indicating substantial price volatility.
*   **Alpha:**  Alpha is a measure of excess return relative to the market. Recent negative alpha figures (-172.0%, -298.0%) indicate significant underperformance.
*   **Beta:**  Beta measures volatility relative to the market.  Values near 0 suggest low correlation with the market, while a negative beta (-0.4 for 2023-2025) implies that ALB may move in the opposite direction of the market.
*   **Cap(B):** The company's capitalization in billions of dollars.

**2. Recent Price Action**

*   **Current Price:** 89.82
*   **Last Market Data:** Price: 89.91, Previous Close: 96.5, Change: -6.83
*   **5-day Moving Average:** 90.46
*   **20-day Moving Average:** 84.09
*   **60-day Moving Average:** 79.88

**Analysis:** The recent price drop (-6.83) is a significant move.  The price is currently below the 5-day moving average but above the 20 and 60-day moving averages, suggesting a potential short-term pullback within a longer-term upward trend.

**3. Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 61.94
*   **PPO:** 0.87
*   **Hybrid Signal:** "cash\_0% Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)"
*   **Recent (20-day) Relative Divergence Change:** 1.8 (+) - Short-term Increase
*   **Expected Return:** 1078.0% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** A high MRI suggests the system views the stock as relatively safe for investment despite the volatility.
*   **RSI:** An RSI of 61.94 is approaching overbought territory, suggesting the price may be due for a consolidation or pullback.
*   **PPO:** A positive PPO indicates that the shorter-term moving average is above the longer-term moving average, suggesting an upward trend.
*   **Hybrid Signal:** The signal suggests a strong buy recommendation, allocating 100% of available cash.
*   **Recent Divergence Change:** The increase in relative divergence suggests ALB is starting to outperform the S&P 500 in the short term.
*   **Expected Return:** The extremely high expected return should be viewed with caution.  It's an optimistic projection based on the model and may not be realistic.

**4. Recent News & Significant Events**

*   **Rare Earths and Miner Stocks Soared:** News about China limiting rare earth exports is driving up mining stocks, which could positively impact ALB if it has exposure to relevant materials.
*   **Analyst Price Target Adjustment:** TD Cowen adjusted its price target *upward* to $85 (from $70), but maintains a "Hold" rating. This suggests a moderately positive outlook.
*   **Analyst Optimism Ahead of Earnings:**  There's anticipation that earnings could signal a turning point.
*   **Catalysts Shaping Albemarle:**  Focus on the evolving factors influencing the company's performance.

**4-2. Analyst Opinions**

*   **Consensus:** "Hold" (Mean: 2.64)
*   **Target Price:** Average: $88.47, High: $200.00, Low: $58.00
*   **Recent Rating Changes:** No recent rating changes are indicated.

**Analysis:** The analyst consensus is neutral ("Hold"). The wide range in target prices indicates significant uncertainty about the stock's future performance.

**5. Recent Earnings Analysis**

| 날짜       |   EPS | 매출      |
|:-----------|------:|:----------|
| 2025-08-04 | -0.16 | 1.33 B$   |
| 2025-04-30 |  0    | 1.08 B$   |
| 2024-11-06 | -9.45 | 1.35 B$   |
| 2024-07-31 | -1.96 | 1.43 B$   |
| 2025-08-04 | -1.96 | 1.43 B$   |

**Analysis:** Recent EPS (Earnings Per Share) figures are negative or near zero, indicating profitability challenges. Revenue has fluctuated but generally remains above $1 billion. The large negative EPS in 2024-11-06 is concerning and should be investigated further.

**6. Financial Information**

| Quarter      | Revenue   | Profit Margin   |
|:-------------|:----------|:----------------|
| 2025-06-30   | \$1.33B   | 14.80%          |
| 2025-03-31   | \$1.08B   | 14.51%          |
| 2024-12-31   | \$1.23B   | 11.22%          |
| 2024-09-30   | \$1.35B   | -7.68%          |
| 2024-06-30   | \$1.43B   | -0.74%          |

| Quarter      | Equity    | ROE     |
|:-------------|:----------|:--------|
| 2025-06-30   | \$10.24B  | 0.22%   |
| 2025-03-31   | \$10.03B  | 0.41%   |
| 2024-12-31   | \$9.96B   | 0.76%   |
| 2024-09-30   | \$10.24B  | -10.44% |
| 2024-06-30   | \$11.22B  | -1.68%  |

**Analysis:**

*   **Revenue & Profitability:** Revenue has been relatively stable, but profit margins have been volatile, with recent quarters showing improvement after periods of negative margins.
*   **Capital & Profitability:** Equity has decreased slightly, and Return on Equity (ROE) has been low or negative, reflecting the profitability issues.

**7. Overall Analysis**

Albemarle (ALB) is facing significant challenges, as reflected in its underperformance compared to the S&P 500, recent negative earnings, and volatile profit margins. The high MDD values, negative alpha values in recent years and negative returns in the recent 2 years compared to the S\&P500 makes one cautious about investing in ALB. However, the Market Risk Indicator suggests the stock is safe for investment and the Hybrid Signal gives a strong buy recommendation allocating 100% of available cash.

The recent price decline, coupled with the analyst consensus "Hold" rating and wide target price range, indicates substantial uncertainty. However, some analysts are suggesting the next earnings report could signal a turning point. The news regarding rare earth exports could be a positive catalyst. The stock is showing a potential short-term recovery, but it's essential to monitor the underlying financial performance and the impact of external factors like the rare earth market.
